Celator Pharmaceuticals, Inc. Issued U.S. Patent Related to CombiPlex(R) Technology Platform
Published: Dec 16, 2010
PRINCETON, N.J.--(BUSINESS WIRE)--Celator Pharmaceuticals today announced the United States Patent and Trademark Office issued U.S Patent No. 7,850,990. This patent adds to the intellectual property surrounding Celator’s innovative technology platforms and products.